The acquisition extends Excelra’s AI, machine learning, and data science capabilities, and enhances its platform and service portfolio. BOSTON — Gent, Belgium & Hyderabad, India: Excelra, a leading life science data and digital solutions provider, has acquired BISC Global, a bioinformatics and data analytics consulting company with offices across Europe and the USA. The acquisition creates […]
Flagship Facility Services is pleased to announce the acquisition of Biotechnical Services, Inc. (BTS) – an independent laboratory services company headquartered in San Diego, California. BTS provides ongoing quality services and support to sustain innovation in Biotech. The company’s main services are lab equipment repair, calibration, and maintenance. Integrating BTS’s services with Flagship’s lab services […]
SOUTHLAKE, Texas — Flagship Facility Services is pleased to announce the acquisition of Biotechnical Services, Inc. (BTS) – an independent laboratory services company headquartered in San Diego, California. BTS provides ongoing quality services and support to sustain innovation in Biotech. The company’s main services are lab equipment repair, calibration, and maintenance. Integrating BTS’s services with Flagship’s lab services capabilities will bring the […]
ARCHIMED first bought 90 percent of Polyplus in 2016, and moved to co-lead the partnership with Warburg Pincus in 2020, after selling half of ARCHIMED’s stake for a 70x multiple on invested capital. With the agreement to sell Strasbourg, France-based Polyplus for €2.4 billion ($2.6 billion), to listed Sartorius Stedim Biotech S.A. (DIM: EN Paris), […]
SAN DIEGO, CA – AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. The purchase of Cell Systems will further enhance AnaBios’ unique human tissue and cells portfolio and help scientists expedite drug discovery and further their understanding of cell biology through […]
TOKYO — Evident Corporation (“Evident”) announced today that it has been acquired by private equity firm Bain Capital Private Equity (“Bain Capital”) from Olympus Corporation (“Olympus”) pursuant to the definitive agreement signed on August 29, 2022. Evident was newly established on April 1, 2022 as a wholly owned subsidiary of Olympus comprising the former Scientific […]
New leadership team, led by Dr Ben Cliff, will drive growth in pharmaceutical development and discovery & biologics Limerston Capital LLP (Limerston Capital) has announced the acquisition of Concept Life Sciences, a leading integrated drug discovery, development and manufacturing organisation, in a carve-out from Spectris plc. The deal will see Concept Life Sciences cement its […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its investment in Wilson Wolf Manufacturing. Wilson Wolf achieved the trailing 12-month earnings before interest, taxes, depreciation, and amortization (EBITDA) target of $55 million, triggering Bio-Techne’s initial investment in the company. Bio-Techne’s $257 million investment gives the Company a 20% ownership stake in Wilson […]
France-based Polyplus is a provider of innovative upstream technologies for cell and gene therapies Polyplus’ transfection reagents and plasmids are key components in the manufacturing of viral vectors Agreed purchase price of approximately 2.4 billion euros Aubagne — Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has signed an agreement to […]
Olympus Corporation (“Olympus”) hereby announces that the closing date of the transfer of all shares of Evident Corporation, a specified subsidiary of Olympus, to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”) (the “Transfer”) has been scheduled for April 3, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
